U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes

New formulation of medicines that helps lower blood sugar in type 2 diabetes can be taken once a day
Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news